Introduction
The fos oncogenes transform cells by functioning as part of AP-1 transcription factor complexes that consist of heterodimers of Fos and Jun family proteins, thereby initiating and maintaining transformation by changes in gene expression (Eferl and Wagner, 2003) . Based upon previous studies, designed to identify genes differentially expressed as a consequence of v-Fos FBR transformation of 208F rat fibroblasts, we proposed that AP-1 regulates a multigenic invasion programme (Hennigan et al., 1994; Lamb et al., 1997a, b; Johnston et al., 2000; Ozanne et al., 2000; Spence et al., 2000) . Using an in vitro invasion/3-D migration assay, we demonstrated that FBR cells are highly invasive and that invasion is dependent upon AP-1 activity (Hennigan et al., 1994; Lamb et al., 1997a, b) . Functional analysis of differentially expressed genes demonstrates that invasion is dependent upon the activity of upregulated genes (Lamb et al., 1997a, b; Spence et al., 2000) and is inhibited by re-expression of a single downregulated gene . This established that re-expression of downregulated genes in FBR cells might be incompatible with invasion. Two of the genes we found upregulated in v-Fos FBRtransformed cells, SAP18 and RbAp46, are components of large protein complexes with histone deacetylase (HDAC) activity, which are involved in gene silencing, for example, Sin3 and Mi-2/NuRD complexes (Zhang et al., 1997 (Zhang et al., , 1999 . Increased or redirected HDAC activity clearly plays an important role in Fos transformation, particularly since trichostatin A (TSA), a specific and potent HDAC inhibitor, prevents Fos-mediated morphological transformation (Bakin and Curran, 1999) .
The acetylation status of histones is an important factor in controlling gene expression (Grunstein, 1997) . It is regulated by competing activities of histone acetyltransferases (HATs) and HDACs, which are recruited to target genes by transcriptional activators or repressors, respectively (Kuo and Allis, 1998; Kouzarides, 2000) . Acetylation of specific lysine residues in the N-terminal 'tail' of histone H4 is associated with transcriptional stimulation, while their deacetylation is associated with transcriptional suppression. Both acetylation and deacetylation have been demonstrated to play significant roles in oncogenic transformation and tumorigenesis (Timmermann et al., 2001; Lehrmann et al., 2002) . Inhibition of HDAC activity in a variety of oncogene-transformed and tumour-derived cell lines by an increasing number of potent and specific inhibitors, such as TSA (Yoshida et al., 1990) and valproic acid (VPA) (Gottlicher et al., 2001) , results in morphological reversion of oncogenic transformation Sugita et al., 1992; Kwon et al., 1998; Bakin and Curran, 1999) , cessation of cell growth, differentiation and apoptosis (Kelly et al., 2002; Marks et al., 2003) .
Epigenetic silencing of gene expression has been implicated in Fos-transformation by the demonstration that the DNA methyltransferase, Dnmt1, was upregulated upon v-Fos FBJ/R transformation and that the treatment of cells with 5-azadeoxycytidine, an inhibitor of Dnmt1, blocked Fos-mediated transformation, as did treatment of cells with TSA (Bakin and Curran, 1999) . The aim of this study was to determine if HDAC activity is necessary for invasion of Fos-transformed cells, and if any of the genes that are downregulated in FBR cells are transcriptionally repressed either directly or indirectly by HDAC activity and if their re-expression in Fos-transformed cells is incompatible with the invasive phenotype. If so, it would indicate that their downregulation was a necessary component of the AP-1 directed multigenic invasion programme.
Results

HDAC inhibition reverts morphological transformation
Treatment of v-Fos FBR -transformed (FBR) cells with the HDAC inhibitors, TSA and VPA, induces morphological reversion and the reassembly of actin stress fibres, such that they resemble parental 208F cells ( Figure  1a,b) . Significantly, this phenotypic reversion can be achieved at concentrations of inhibitors (12 nM TSA and 50 mg ml À1 VPA) that have no effect on proliferation (Figure 1c) . Although it is known that inhibitors of HDAC activity inhibit cell cycle progression (Rosato et al., 2003) , dose response experiments with TSA and , respectively, FBR cell proliferation is unaffected (Figure 1c ). In addition, the TSA-and VPA-induced morphological changes are reversible, cells return to a fully transformed morphology by 4 days after the removal of inhibitor (Figure 1d ), or more quickly if the cells are passaged (data not shown). These results demonstrate that morphological transformation and actin rearrangement, by v-Fos FBR , is mediated by HDACs.
TSA and VPA inhibit invasion
We determined the effect HDAC inhibitors have on the highly invasive phenotype of FBR cells. In an in vitro invasion assay (which measures 3-D migration), TSA and VPA inhibit invasion in a dose-dependent manner. At 4 nM, TSA inhibits FBR cell invasion by 80% and, at 8 nM, by over 90% (Figure 2a,b) . VPA, at 25 mg ml À1 , inhibits invasion by over 90% and, at 50 mg ml
À1
, by over 95% (Figure 2a, b) . This dramatic inhibition of 3-D migration is achieved at concentrations of inhibitors lower than those required to facilitate morphological reversion or to inhibit growth. We related these results to the effect of TSA or VPA on the motility of FBR cells, as determined by scrape wound assays (which measure 2-D migration), and demonstrated that invasion is inhibited at concentrations of the inhibitor that do not affect motility (Figure 2c ). The possibility that inhibition of invasion is actually a consequence of impaired chemotaxis, is excluded by analysis of the invasion assays. The migration of cells from the bottom to the top of the filter is a measure of chemotaxis since we have previously shown that FBR cells will not migrate to the upper surface of the filter in the absence of matrigel or serum (Hennigan et al., 1994; Lamb et al., 1997a) . We found that the proportion of FBR cells migrating to the top of the filter is unaffected by HDAC inhibitor treatment ( Figure 2d ). 
Re-expression of downregulated genes inhibits invasion
As we have shown, inhibition of HDACs both inhibits invasion and allows the re-expression of genes downregulated in Fos-transformed cells. To determine if re-expression of these HDAC-regulated genes is incompatible with the invasive phenotype, cDNAs of: STAT6, a transcription factor; RYBP, a transcription co-factor; and PCDHGC3, a cell-cell interaction protein, were 3 0 -EGFP-tagged and introduced into FBR cells by nucleofection; an adaptation of the electroporation method, which delivers the vector directly to the nucleus with greater than 80% efficiency. Thus we were able to study transient, as well as, stable expression of these genes in FBR cells. Western blotting determined that molecular weights were as expected for each protein including the 27 kDa EGFP tag (Figure 4a ). Without EGFP-tags: RYBP is 32 kDa (Garcia et al., 1999) ; PCDHGC3 (protocadherin 43) is approximately 135 kDa (Sano et al., 1993) ; and STAT6, reportedly two bands, has the major species at 102 kDa (Quelle et al., 1995) .
The intracellular location of each EGFP-tagged protein was determined by fluorescence microscopy of fixed cells, counter-stained with TRITC-phalloidin to detect F-actin. The distribution of the proteins was also as expected ( Figure 4b ) and the distribution of F-actin was unaffected. The EGFP expressed by the emptyvector control is uniformly distributed within the cell; RYBP is exclusively located in the nucleus; STAT6 is concentrated in the nucleus but with some cytoplasmic expression, consistent with its role as a transcription factor that shuttles between the cytoplasm and nucleus; and PCDHGC3 is primarily located in the plasma membrane as anticipated. For all three proteins, in comparing transient versus stable transfectants there was no apparent difference in their distribution and localization within the FBR cell.
The effect that re-expressing these genes in Fostransformed cells has on invasive ability was determined by in vitro invasion/3-D migration assay. We found that both stable and transient expression of EGFP-tagged: RYBP, PCDHGC3 or STAT6 strongly suppressed invasion (Figure 5a ), while those FBR cells expressing only EGFP were as invasive as control FBR cells. Since all three genes inhibited invasion, we subsequently included assays of FBR cell lines stably overexpressing To discount other possible explanations for the inhibition of invasion, we measured the growth rate of the transfectants, their chemotactic response and their motility (2-D migration). Cell counts performed on cultured cells after 4 days (the duration of the invasion assay) established that the re-expression of RYBP, PCDHGC3 or STAT6 (Figure 5b ) did not affect proliferation. As with the HDAC inhibitor studies, the possibility that the transfected cells are unable to invade due to impaired chemotaxis was investigated by analysis of the invasion assays. We found that the number of FBR cells migrating to the top of the filter is unaffected by the expression of RYBP, PDCHGC3 or STAT6 (Figure 5c ), despite the marked effect on their migration into the matrigel itself. To compare the ability of the cell populations to migrate in two dimensions, we used scrape wound assays, with time-lapse microscopy, to follow the movement of cells into a wound. In each case, the rate of migration was unaffected by the ectopically expressed proteins (Figure 5d ). These data, taken together, show that the inhibition of invasion of the FBR cells by re-expression of RYPB, PDCH2 or STAT6 is not due to impaired growth, chemotaxis or 2-D migration, rather, it reflects an inability of the cells to invade three dimensionally in matrigel, thereby demonstrating that the expression of each protein is incompatible with the FBR cells invasion/3-D migration.
Discussion
HDAC inhibitors are currently in clinical trials as anticancer agents, primarily because they inhibit proliferation and induce terminal differentiation or apoptosis. Here, we demonstrate another possible role for HDAC inhibitors in the treatment of cancer, as inhibitors of invasion. Inhibition of HDAC activity reverses morphological transformation of cells transformed by fos, src and ras oncogenes Sugita et al., 1992; Kwon et al., 1998; Bakin and Curran, 1999 , 2003) . In animal models, HDAC inhibitors reduce tumour proliferation and inhibit metastasis (Imai et al., 2003) .
Inhibitors of HDACs suppress tumour growth and invasion, at least in part, by relieving repression of expression of downregulated genes (Liu et al., 2003; Masui et al., 2003; Yamashita et al., 2003) . Here, we confirm that HDAC activity is required for the maintenance of transformed morphology and demonstrate that it is necessary for the invasion of FBR cells. Significantly, invasion can be inhibited by concentrations of TSA or VPA, which are less than that required to revert the transformed morphology, or to inhibit proliferation, 2-D migration or chemotaxis. This is an important point. It demonstrates that it is possible to inhibit invasion without affecting other parameters of transformation, and demonstrates that morphological reversion and reappearance of actin stress fibres is not necessary for the cells to become noninvasive. This establishes that morphological transformation or spindle cell appearance is not sufficient for invasion.
The transforming activity of Fos oncoproteins is dependent upon their ability to regulate gene expression. Previously, we identified genes that are up-and downregulated as a consequence of v-Fos FBR expression. In this study, we have used HDAC inhibitors to demonstrate that HDAC activity is responsible for the downregulation of some, but not all, of these genes in Fos-transformed cells. Treatment of FBR cells with both TSA and VPA results in the increased expression of at least five genes, to the levels observed in untransformed 208F cells. Three of these genes, STAT6, RYBP and PCDHGC3, not previously associated with the invasive phenotype, when expressed individually in FBR cells are potent inhibitors of invasion/3-D migration without any effect on cellular morphology, actin stress-fibres, 2-D migration or proliferation. It is surprising that each of these genes, with distinct functions, when expressed in FBRs, only inhibit invasion and that in each case expression of a single gene is sufficient to do so. This strongly indicates that the genes are downregulated because their expression is incompatible with invasion. In this context, it is notable that expression of other genes, either upregulated or not differentially expressed, does not inhibit invasion. This validates each gene tested here as a member of the proposed AP-1 regulated multigenic invasion programme Ozanne et al., 2000) . An important tenet of a programme is that each unit in the programme (a gene) functions to achieve the aim of the programme. For downregulated genes, their expression is inconsistent with invasion/3-D migration as demonstrated here by forced expression of the downregulated genes in FBR cells. The finding that HDAC inhibitors severely restrict invasion suggests that HDAC activity is a positive regulator of the multigenic invasion programme.
The effect of HDAC inhibitors on morphology and invasion/3-D migration suggests that epigenetic repression of gene expression plays an important role in these characteristics of transformation, although not all of the repressed genes regulate both characteristics simultaneously. HDAC inhibitor-mediated suppression of invasion occurs at concentrations below that required for the alteration of cell morphology, 2-D migration, chemotaxis or proliferation, indicating that cellular functions beyond morphology, motility and sensing of chemoattractants are required for invasion/3-D migration. This inhibition of invasion is not due to a longterm accommodation of the cell to expression of the repressed genes, since inhibition of invasion follows transient expression of the genes in FBR cells as well as stable expression. The mechanisms by which these genes affect invasion, presently, can only be surmised by the known function of the genes. RYBP and STAT6 are transcription modifiers and presumably inhibit invasion by altering gene expression. The targets of these genes in this context remain to be identified, but suggest that the v-Fos-regulated multigenic invasion programme consists of a transcriptional cascade or network that controls the effectors and inhibitors of invasion.
RYBP, a relatively recently discovered transcription co-factor (Garcia et al., 1999) , interacts with the transcription factors, YY1, E2F2, E2F3, E2F6 and the polycomb complex proteins, Ring1 and M33, but does not recognize a DNA sequence as a binding site (Garcia et al., 1999; Trimarchi et al., 2001; Schlisio et al., 2002) . Depending upon the transcription factor, RYBP could function as a transcriptional repressor or activator. In the context of Fos-transformation, its role awaits further investigation; however, it would seem less likely to be through interaction with E2F2 and E2F3, which stimulates expression of the cell cycle regulator Cdc6 (Schlisio et al., 2002) , as the rate of cell cycle progression does not appear to be altered upon re-expression of RYBP, either by HDAC inhibitor treatment or by transgene. It may be that RYBP functions through interaction with the polycomb group proteins suppressing gene expression; however, since the role of E2F6 is not clearly defined, it could be a co-factor for E2F6, which is itself a component of the mammalian Bmi1-containing polycomb complex that functions to suppress gene expression (Trimarchi et al., 2001) . There is of course the possibility that there are yet undiscovered transcription factors that RYBP interacts with.
STAT6, an interleukin (IL)-4 and IL-13-regulated transcription factor, is also downregulated in FBR cells relative to 208F cells and its expression is returned to 208F levels following HDAC inhibition. The role of STAT6 in Fos-transformation may be related to its role in regulating matrix metalloproteinases (MMPs) gene expression or altering expression of extracellular matrix components (McGaha et al., 2003; Buttner et al., 2004) .
PCDHGC3 is a member of the large protocadherin family of proteins (Sano et al., 1993; Suzuki, 2000) . PCDHGC3 has six extracellular cadherin repeats and participates in calcium-dependent homophilic cell-cell adhesions. PCDHGC3 is known to be expressed in the brain, but we find the mRNA relatively abundant in 208F cells. Since the PCDHGC3-expressing FBR cells do not display altered morphology or 2-D migration, it may have a subtle effect on invasion/3-D migration.
It is striking that the two simplest explanations by which inhibition of HDAC activity or expression of each of the HDAC-regulated genes block invasion/3-D migration, impaired motility or impaired chemotaxis are excluded by their failure to affect either. The wound healing assays indicate that 2-D migration is unaffected, while the migration of the cells from the bottom to the top of the filter in response to matrigel indicates that their chemotactic response remains intact.
It should be noted that the expression of cDNAs in FBR cells per se does not alter the invasion of the cells. Here we demonstrated that HDAC4, an upregulated gene (data not shown), and 14-3-3b, which is not differentially expressed (data not shown), had no effect on the invasiveness of FBR cells. Previously we have demonstrated that expression of cDNAs encoding CD44 and ezrin, both upregulated genes, did not enhance or inhibit the invasion of FBR cells; neither did increased CD44, ezrin (Lamb et al., 1997a, b) or HDAC4 (unpublished data) expression in 208F cells render them invasive.
The finding that three HDAC-repressed genes all affect invasion/3-D migration without affecting proliferation or 2-D migration strongly suggests that the invasion programme must be intact for invasion to take place and that genes are downregulated because the invasion programme is being activated. In this context, it is significant perhaps that the Fos-transformed cells were not selected for invasiveness; rather it seems to be the unpredicted consequence of a sustained increase in AP-1 activity that leads to the activation of the AP-1-regulated multigenic invasion programme.
Materials and methods
Cell lines
The origin and in vitro culture of the 208F and FBR cell lines are as previously described (Hennigan et al., 1994) . G418 (Geneticin) (Invitrogen), to a final concentration of 700 mg ml
À1
, was also added to Dulbecco's minimum essential medium (Invitrogen) used to maintain those cell lines carrying stably transfected genes.
F-actin staining
Cells were seeded at 5 Â 10 3 on sterile glass coverslips (19 mm) in 1.5 cm diameter tissue culture wells and grown as described above. At stated time points, sodium valproate (Sigma) or TSA (Sigma) was added at indicated concentrations, where required, to the medium (which was replaced every 48 h), so that cells were fixed at equivalent confluence on the same day, irrespective of the length of treatment. Cells were then stained with FITC-or TRITC-conjugated-phalloidin and visualized as previously described (Lamb et al., 1997b) , with the exceptions that staining was for 15 min and a Â 60 objective was used.
Growth curves
Cells were seeded in multiple wells of 3.6 cm diameter tissue culture plates at 2 Â 10 4 or 4 Â 10 4 per well, medium was changed every 2 days and cells were counted (from four wells per sample) on indicated days using a Sha¨rfe Casy1 TT Cell Counter.
Invasion/3-D migration assays
Inverse invasion assays were carried out as previously described (Hennigan et al., 1994) with exceptions that reduced growth factor matrigel (BD Biosciences) was used, cells were seeded at 2 Â 10 4 per Transwell and DMEM above the matrigel contained 10% FCS. Where an HDAC inhibitor was used, it was added to the matrigel and to the medium above and below, to the final concentration stated. Cells were fixed and stained with calcein AM (Scott et al., 2004) . Confocal microscopy and quantitation was largely as previously described (Hennigan et al., 1994) , with exceptions that a positive pixel is defined as one with an intensity value greater than operator-defined background and that optical sections were scanned at 3 mm intervals. Only cells in the 9 mm section or above were considered invasive for quantitation purposes. A compound image of these sections was quantified (Hennigan et al., 1994) , then normalized to the value obtained from the corresponding 0 mm section as a 'loading' control. Overall results were determined from at least three separate assays performed at least in duplicate.
Motility assays
Cells were seeded at 7 Â 10 4 in 3.6 cm diameter wells, 3 days prior to wounding, in the absence or presence of VPA or TSA at the required concentration. A single wound was made down the centre of each well using the 200 ml tip from a Gilson Pipetman. Medium was then replaced with VPA or TSA, if required. Phase contrast timelapse images were captured at 20 min intervals over a 24 h period, on a Zeiss Axiovert 200 m with a Hamamatsu Orca camera, while plates were incubated in a Solent CO 2 incubator designed around a Ludl microscope stage. The timelapse stage manipulation and captured images were handled using AQM software by Kinetic Imaging.
For each assay, we chose the time point immediately before cells where the edges of the wound begin to meet, to avoid cellcell contact effects. We measured the width of the wound in the centre of the field at this time point, compared to the size at t ¼ 0, to determine the rate of movement of the cells into the wound. Each experiment was repeated three times.
RNA extraction and Northern blotting
Cells were grown to 70% confluence in 10 cm tissue culture dishes. Total cellular RNA extraction and Northern blotting was as previously described . Probes were derived, by PCR, from the appropriate gene-specific, subtractive cDNA library, clone, using vector-specific primer sequences .
Hybridization was carried out in 'Expresshyb' (BD Biosciences/Clontech) following the manufacturer's protocol. To control for RNA loading, membranes were stripped and reprobed for 7s ribosomal RNA using established procedures (Sambrook et al., 1989) .
Cloning RYBP (Garcia et al., 1999) , STAT6 (Quelle et al., 1995) and PCDHGC3 (protocadherin 43) (Sano et al., 1993) , full-length cDNAs were kind gifts from Miguel Vidal, Centro De Investigaciones Biologicas, Madrid, Spain; James Ihle, St Jude Children's Research Hospital, Memphis, USA; and Shintaro T. Suzuki, Kwanseigakuin University, Hyogo, Japan, respectively.
Using established PCR and molecular cloning methods, each cDNA was amplified, using Turbo pfu (Stratagene), from its original vector using 30 base primers specific for the 5 0 and 3 0 sequences of the cDNAs, which were flanked by an EcoR1 site plus a further six-base spacer sequence. The PCR products were blunt-end ligated into the PCR-Script vector (Stratagene), then excised using the appropriate restriction enzyme and ligated into the pEGFP-N1 (BD Biosciences/Clontech), which provides a C-terminal EGFP tag. Ligation of genes into vectors was achieved using a Rapid DNA Ligation Kit (Stratagene), following the recommended procedure. We confirmed the accuracy of the sequence of the cloned genes and of the gene/vector junctions by DNA sequencing and demonstrated, by Western analysis, the expression of a protein of the expected molecular weight, in Cos 7 cells.
Western analysis
Cells were grown to approximately 70% confluence in 10 cm dishes, then following previously described methods (Stapleton et al., 2002) harvested into RIPA buffer, the proteins quantified, separated by polyacrylamide gel electrophoresis (25 mg protein per lane), transferred to membrane and hybridized to antibody, as previously described (Lamb et al., 1997a) . 'Living Colors' A.v. monoclonal antibody JL-8 (BD Biosciences/Clontech) to EGFP was used at a 1 : 3000 dilution and HRP-conjugated sheep anti-mouse Ig (Amersham) at a 1 : 5000 dilution.
Nucleofection
Nucleofection was carried out using an Amaxa Nucleofector, according to the manufacturer's protocol, using nucleofection solution R and programme T-20. To create stable cell lines, immediately postnucleofection a 10 cm dish was seeded, with 1/40th volume of one nucleofection, in DMEM plus 10% FCS. Cells were incubated for 24 h before the medium was replaced with DMEM plus 10% FCS, containing G418 (700 mg ml
À1
). Cells were then incubated for 2 weeks during which time medium was replaced daily. The resultant G418 resistant population was then FACS-sorted for green fluorescence, yielding a single pool of cells for each nucleofection.
To create transiently expressing cells, immediately postnucleofection, cells were seeded either for counting or directly into invasion assays; we also confirmed by fluorescence microscopy, on each occasion, that more than 80% of the cells were expressing the transgene.
Chemotaxis
Chemotaxis was measured using the results from the invasion assay. Here we quantified the 3 mm section, which shows cells that have migrated only to the upper surface of the filter but not into the matrigel, and normalized it to the 0 mm in the same way as we did for the invasion assays.
